🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06323772
Active, not recruiting Observational

Natural History Study in Patients With PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa

NCT06323772 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2023-11-17
Last updated
2026-05-06

Condition(s) studied

Retinitis Pigmentosa

Study summary

The aim of the study is to apply a novel clinical investigation protocol in patients with Phosphodiesterase 6A (PDE6A), PDE6B and Rhodopsin (RHO)-based retinitis pigmentosa. This novel, multimodal clinical examination protocol describes and correlates structural, functional and metabolic aspects during natural disease development.

Test-retest variability of new measurements as well as correlations of the structural, functional, and metabolic changes will be defined to be able to define well-suited readouts for safety and efficacy of future treatment developments before they reach the clinical phase.

Eligibility

Sex
ALL
Min age
5 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age: from 5 years of age * Patient with PDE6A, PDE6B, and RHO-based retinitis pigmentosa * Patient and/or legal representatives are willing and able to give written informed consent Exclusion Criteria: * severe general disease, that would make longer examinations not possible

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institute for Ophthalmic Research, University Tübingen Tübingen Baden-Wurttemberg

More University Hospital Tuebingen trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06323772 on ClinicalTrials.gov ↗ ← All trials in Germany